Issue 7/2023
Special issue: New treatment strategies for mental health
Content (19 Articles)
TDCS at home for depressive disorders: an updated systematic review and lessons learned from a prematurely terminated randomized controlled pilot study
Ulrike Kumpf, Ulrich Palm, Julia Eder, Harry Ezim, Matthias Stadler, Gerrit Burkhardt, Esther Dechantsreiter, Frank Padberg
White matter predicts tDCS antidepressant effects in a sham-controlled clinical trial study
Tamires A. Zanao, Matthias S. Luethi, Stephan Goerigk, Paulo Suen, Alexandre P. Diaz, Jair C. Soares, Andre R. Brunoni
Antidepressant effects of prolonged intermittent theta-burst stimulation monotherapy at the bilateral dorsomedial prefrontal cortex for medication and standard transcranial magnetic stimulation-resistant major depression: a three arm, randomized, double blind, sham-controlled pilot study
Chih-Ming Cheng, Cheng-Ta Li, Jia-Shyun Jeng, Wen-Han Chang, Wei-Chen Lin, Mu-Hong Chen, Ya-Mei Bai, Shih-Jen Tsai, Tung-Ping Su
mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
Shigeyuki Chaki, Mai Watanabe
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Maurizio Fava, Stephen M. Stahl, Sara De Martin, Andrea Mattarei, Ezio Bettini, Stefano Comai, Andrea Alimonti, Francesco Bifari, Luca Pani, Franco Folli, Clotilde Guidetti, Alberto Furlan, Jacopo Sgrignani, Patrizia Locatelli, Andrea Cavalli, Cedric O’Gorman, Sergio Traversa, Charles E. Inturrisi, Marco Pappagallo, Paolo L. Manfredi
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options
Rainer Rupprecht, Arpit Kumar Pradhan, Marco Kufner, Lisa Marie Brunner, Caroline Nothdurfter, Simon Wein, Jens Schwarzbach, Xenia Puig, Christian Rupprecht, Gerhard Rammes
Functional connectivity changes between amygdala and prefrontal cortex after ECT are associated with improvement in distinct depressive symptoms
Ann-Kathrin Domke, Moritz Hempel, Corinna Hartling, Anna Stippl, Luisa Carstens, Rebecca Gruzman, Ana Lucia Herrera Melendez, Malek Bajbouj, Matti Gärtner, Simone Grimm
(R)-ketamine attenuates neurodevelopmental disease-related phenotypes in a mouse model of maternal immune activation
Elifrances Galdino de Oliveira, Diógenes Afonso de Lima, José Carlos da Silva Júnior, Mayara Victória de Souza Barbosa, Severina Cassia de Andrade Silva, Jonata Henrique de Santana, Osmar Henrique dos Santos Junior, Eduardo Carvalho Lira, Claudia Jacques Lagranha, Filipe Silveira Duarte, Dayane Aparecida Gomes
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies
Juliana Mendes Rocha, José A. S. Reis, José Carlos Bouso, Jaime E. C. Hallak, Rafael G. dos Santos
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
Eric D. Achtyes, Seth C. Hopkins, Nina Dedic, Heather Dworak, Courtney Zeni, Kenneth Koblan
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
Holger Rosenbrock, Michael Desch, Glen Wunderlich
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Nazar Kuzo, Ekkehard Haen, Dominic M. Ho, Hiroyoshi Takeuchi, Marianna Piras, Chin-Bin Eap, Renato de Filippis, Philipp Homan, John M. Kane, Marc-André Roy, Michael Paulzen, Georgios Schoretsanitis
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study
Francesco Bartoli, Tommaso Callovini, Daniele Cavaleri, Cristina Crocamo, Ilaria Riboldi, Andrea Aguglia, Pasquale De Fazio, Giovanni Martinotti, Armando D’Agostino, Giovanni Ostuzzi, Corrado Barbui, Giuseppe Carrà
Guideline for schizophrenia: implementation status and attitude toward an upcoming living guideline
Naiiri Khorikian-Ghazari, Carolin Lorenz, Duygu Güler, Theresa Halms, Astrid Röh, Marisa Flick, Angelika Burschinski, Charline Pielenz, Eva Salveridou-Hof, Thomas Schneider-Axmann, Marco Schneider, Elias Wagner, Peter Falkai, Wolfgang Gaebel, Stefan Leucht, Alkomiet Hasan, Gabriele Gaigl
Tübinger Training for Autism Spectrum Disorders (TüTASS): a structured group intervention on self-perception and social skills of children with autism spectrum disorder (ASD)
Laura Luisa Drüsedau, Antonia Götz, Lena Kleine Büning, Annette Conzelmann, Tobias J. Renner, Gottfried M. Barth
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans-Peter Volz, Erich Seifritz, Hans-Jürgen Möller, Sandra Schläfke, Siegfried Kasper